JDCA Frequently Asked Questions
1. Why is a Practical Cure important?
A Practical Cure is what people living with T1D want. It is defined as a lifestyle that frees people from a majority of the burdens of the disease. (Please see the Practical Cure definition included in this Media Kit for a complete definition and examples of how a Practical Cure would impact the lives of people with type 1 diabetes.)
2. How does the JDCA help donors?
The JDCA acts as an adviser and resource for donors who want to ensure that their contributions are used for Practical Cure research. The JDCA writes a series of research reports to analyze the efforts, prospects and obstacles to achieving a Practical Cure in the near future. The JDCA also provide advisory services that allow donors to ensure their donation is used solely for Practical Cure research. Donors are encouraged to schedule personalized consultations in addition to utilizing donor tools available on the JDCA website that clarify the donating process.
3. Is there a minimum amount that a donor needs to contribute before receiving advisory support?
No, the JDCA will work with donors of any size. The resources and donor tools found on our website are relevant to all donors.
4. How is the JDCA funded?
The JDCA is fully funded by its founder through the Brian and Joelle Kelly Family Foundation. The JDCA does not solicit or accept donations. All services are free of charge.
5. Do you receive any compensation from the organizations you cover?
No, the JDCA operates free of conflicts of interest and receive no compensation from the organizations discussed in our reports. We conduct proprietary research and report our findings and conclusions without bias toward any charitable foundation or research approach.
6. Is 2025 a promise or a goal? What is the difference?
2025 represents a goal to help incentivize and stimulate research. A time goal should be an essential criterion when prioritizing research initiatives. Without such a goal, a near term project is on equal footing with a long term one. The JDCA believes that a cure will not be achieved before 2025 without such a goal.
7. Why a research-based approach?
The JDCA takes a business-like approach in our assessment of the prospects for developing a Practical Cure for T1D. The JDCA studies, analyzes and comments on the strategies and operations of the charitable research foundations/organizations we follow within the context of the potential to develop a Practical Cure by 2025.
8. Is the JDCA’s role adversarial to the other non-profits?
JDCA staff maintain contact with leaders of all the organizations we cover. The JDCA aims to be pragmatic, professional and constructive. The interactions are generally collaborative, but there are also times when the level of collaboration is not as high as we would hope for.
The bottom line is that donors want to see a change in resource allocation and research prioritization practices that have been established over time. Without a paradigm shift the JDCA strongly believes there will not be a Practical Cure in the foreseeable future.